Abiopharma

🔍 Yap Kim Choy (Executive)

Company: Cyclacel Pharmaceuticals, Inc. (CYCC)

Report Date: 2025-09-04

Detailed Transactions and Holdings:

• Acquired 186,465 shares of Common Stock (Direct)
  Date: 2025-09-04 | Code: J | equity_swap_involved: 0 | shares_owned_after: 404,465.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 186,465 shares of Series C Common Stock Warrants at $10.2 per share (Derivative)
  Date: 2025-09-04 | Code: J | Expires: 2030-06-20 | Exercise: 2025-06-20 | equity_swap_involved: 0 | shares_owned_after: 31,535.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025.